TD Asset Management Inc

Position in AZN — Astrazeneca PLC

CIK 1056053 Toronto, A6

Position in AZN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$387,642,812

New position

Shares Held

1,965,535

first reported quarter

Ownership

0.127%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $4,569,308,928 across 12 Drug Manufacturers - General names. AZN ranks #5 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,565,498	$1,115,990,330
2	LLY	ELI LILLY & Co	1,190,111	$1,094,628,394
3	ABBV	AbbVie Inc.	3,920,076	$852,577,328
4	GILD	Gilead Sciences, Inc.	3,372,079	$469,966,650
5	AZN	Astrazeneca PLC This page	1,965,535	$387,642,812
6	MRK	Merck & Co., Inc.	2,288,576	$275,292,806
7	AMGN	Amgen Inc	404,449	$142,305,380
8	PFE	Pfizer Inc	4,157,133	$116,732,294

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$387,642,812	1,965,535	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.